Search the Newsreel

Strata Critical Medical, Inc. (SRTA) stock price, news, quote and history

Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”

Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Immersion Investment Partners returned 39.1% in the second quarter, surpassing the Russell 2000 Index's 21.5% gain. The market started valuing their non-AI …

Analysts Are Updating Their Strata Critical Medical, Inc. (NASDAQ:SRTA) Estimates After Its Second-Quarter Results

Strata Critical Medical, Inc. (NASDAQ:SRTA) saw its shares rise 9.8% after its second-quarter results, despite a significant increase in statutory losses per share. Analysts have since updated their estimates, now predicting profitability for the company next year and a notable 12% improvement in 2026 …

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript

Strata Critical Medical reported strong Q2 2026 results with significant sequential growth in clinical revenue and increased clinical gross margins, driven by strategic acquisitions. The company raised its 2026 revenue and adjusted EBITDA guidance, reflecting accelerated clinical growth and M&A, despite short-term logistics margin …

Strata Critical Medical (SRTA) Stock Faces Clinical Progress And Lingering Losses

Strata Critical Medical (SRTA) reported Q2 2026 results showing significant clinical revenue growth, reaching US$72.5m, and improved adjusted EBITDA margins, signaling a successful pivot towards clinical services. Despite these operational improvements and positive free cash flow, the company continues to face losses, a short …

Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SRTA)

This article provides the slide deck published by Strata Critical Medical, Inc. (SRTA) in conjunction with their Q2 2026 earnings call. The content is presented by SA Transcripts, a team dedicated to publishing earnings call transcripts and related developments.

Strata Critical Medical, Inc. 2Q 2026: Revenue $72.51M, EPS ($0.12) — 10-Q Summary

Strata Critical Medical, Inc. reported its Q2 2026 financial results, showing revenue of $72.51 million, a 60.7% increase year-over-year, largely due to Logistics expansion and newly acquired Clinical services. The net loss widened to ($10.52M) with a diluted loss per share of ($0.12). The …

Strata Critical Medical Inc (SRTA) (Q2 2026) Earnings Call Highlights: Revenue Surges 60. ...

Strata Critical Medical Inc (SRTA) reported a 60.7% year-over-year revenue increase to $72.5 million in Q2 2026, driven by strong clinical revenue growth and strategic acquisitions. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, citing outperformance in its base business and …

Strata Critical Medical Q2 Results: Revenue Jumps 60.7% YoY

Strata Critical Medical (NASDAQ: SRTA) grows revenue but posts Q2 loss

Strata Critical Medical Releases Q2 2026 Financial Results

Strata Critical Medical (NASDAQ: SRTA) reported its Q2 2026 financial results, with diluted EPS of -$0.12, missing the $0.01 estimate. Despite a 60.7% increase in revenue to $72.5M year-over-year, the company experienced a net loss of $10.5M, widening its per-share loss from Q2 2025. …

Strata Critical Medical Reports Q2 2026 Revenue Up 60.7% to $72.5M; Adjusted EBITDA $7.9M

Strata Critical Medical (SRTA) reported a significant revenue increase of 60.7% year-over-year, reaching $72.5 million in Q2 2026, primarily driven by the expansion of its Clinical business. The company posted an Adjusted EBITDA of $7.9 million (10.9% margin) and a GAAP net loss of …

Blade Air Mobility reports mixed Q2 results; updates FY26 outlook

* Blade Air Mobility press release [https://seekingalpha.com/pr/20605368-strata-critical-medical-announces-second-quarter-2026-results] (SRTA [https://seekingalpha.com/symbol/SRTA]): Q2 GAAP EPS of -$0.12 misses by $0.10. * Revenue of $72.51M (+60.7% Y/Y) beats by $4.9M. * _Adjusted EBITDA__(1)__ of $7.9 million in Q2 2026; Adjusted EBITDA margin of 10.9%_ * _Cash flow from …

Strata Critical Medical earnings missed by $0.09, revenue topped estimates

Strata Critical Medical (SRTA) CEO granted 57,172 shares from PSU vesting

Strata Critical Medical, Inc. CEO, Scott M. Wunsch, was granted 57,172 shares of Class A common stock on July 30, 2026, due to the vesting of performance-based restricted stock units (PSUs). A portion of these shares, 13,992, were withheld on July 31, 2026, at …

Strata Critical Medical (SRTA) awards 30,913 RSUs to board director

Strata Critical Medical, Inc. (SRTA) board director Philip Edward M was granted 30,913 Restricted Stock Units (RSUs) on July 30, 2026. These RSUs will vest 100% on the date of the company's 2027 Annual Meeting of Stockholders and will be settled in Class A …

Director RSU award: Strata Critical Medical (SRTA) grants 50,234 units

Strata Critical Medical (SRTA) director Robert S. Wiesenthal was granted 50,234 Restricted Stock Units (RSUs) on July 30, 2026. These RSUs, which have a stated price of $0.0000 per share, will fully vest on the date of the company's 2027 Annual Meeting of Stockholders. …

Strata Critical Medical (SRTA) reports PSU vesting and tax share withholding

Strata Critical Medical (SRTA) CAO gets PSU shares; 34,015 withheld

Strata Critical Medical (SRTA) co-CEO receives PSU share awards

Strata Critical Medical Inc (SRTA) Q2 2026 Earnings Report Preview: What To Look For

Strata Critical Medical Ord Shs Class A (SRTA) Institutional Confidence

This article provides an overview of institutional confidence in Strata Critical Medical Ord Shs Class A (SRTA) by detailing major institutional shareholdings and recent changes in their positions. Key investors such as KSL Capital Partners, ARK Investment Management, Wiesenthal (Robert S), and Third Point …

Strata Critical Medical, Inc. Revenue Breakdown – NASDAQ:SRTA

Strata Critical Medical, Inc. (NASDAQ:SRTA) generated $197.14 million USD in revenue last year. The majority of this revenue, $176.79 million USD, came from its Logistics segment. The United States was the primary geographic contributor, accounting for all of the company's revenue last year, a …

Strata Critical Medical Ord Shs Class A (SRTA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Strata Critical Medical Ord Shs Class A (SRTA), listing major shareholders and their respective proportions. It also categorizes shareholders by type and provides a historical breakdown of institutional holdings and recent shareholder activity. The information is crucial …

Price to earnings forward of Strata Critical Medical, Inc. – NASDAQ:SRTA

This article displays the "Price to earnings forward" value for Strata Critical Medical, Inc. (NASDAQ: SRTA) on TradingView. It presents financial data for the company, accessible through the platform's interface. The page itself is a snapshot of various financial metrics available for the company …

SRTA|Strata Critical Medical Ord Shs Class A|Price:5.040|Chg%:-0.050

This article provides a detailed financial overview of Strata Critical Medical Ord Shs Class A (SRTA), including its current stock price, market capitalization, P/E ratio, and recent performance. It also includes analyst ratings, key financial indicators like ROA and ROE, and major shareholders. The …

SRTA Q1 2026 Earnings: EPS Surprises to the Upside as Strata Critical Medical Exceeds Expectations - Estimate Dispersion

Price to sales forward of Strata Critical Medical, Inc. – NASDAQ:SRTA

This page provides information on the forward price-to-sales ratio for Strata Critical Medical, Inc. (NASDAQ: SRTA). It details the company's financial overview within the health services sector and mentions that the market was closed with no trades at the time of publication. The content …

Strata Critical Medical to announce Q2FY26 results on August 4

Strata Critical Medical is scheduled to release its Q2FY26 financial results on August 4, 2026, before the market opens. Following the announcement, Co-CEOs Melissa Tomkiel and Will Heyburn will host a conference call at 8:00 am ET to discuss the company's performance. The company …

Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call

Strata Critical Medical (Nasdaq: SRTA) announced it will release its second-quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens. The company will host a conference call on the same day at 8:00 am ET to discuss the results, featuring Co-CEOs …

Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics

Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?